Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate intubation conditions with the use of atracurium after a fixed three-minute delay


Clinical Trial Description

The recommended dose of a non-depolarizing curare to facilitate tracheal intubation is twice the active dose 95 (the dose that reduces muscle force by 95%). At this dosage, curarization of the laryngeal adductors allowing relaxation and abduction (opening) of the vocal cords is considered certain. With atracurium, the dose for intubation is 0.5 mg.kg-1 and the time to full effect is approximately 3 minutes. With the use of newer hypnotics, there are no data evaluating the conditions for intubation after a fixed time of 3 minutes as with current anesthetic practices. ;


Study Design


Related Conditions & MeSH terms

  • Obesity Female Patients Require General Anaesthesia With Intubation and Atracurium Curarization

NCT number NCT04808440
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase
Start date March 23, 2021
Completion date September 7, 2021